A massive dataset of 1.2M brain cells shines a light on disease’s cellular roots.
The BRAIN Initiative supports the development of a diverse portfolio of biomolecular tools and emphasizes their rapid and broad dissemination to the research community. Browse the Addgene collection of plasmids created with support from the BRAIN Initiative.
Today the National Institutes of Health announces two transformative projects supported by the Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative: The BRAIN Initiative® Cell Atlas Network (BICAN) and the
This BRAIN Initiative FOA is to further develop molecular tools of high impact that are targetable to brain cell types for the monitoring and manipulation of neural circuits in experimental animals. This FOA is part of the BRAIN Initiative Armamentarium for Brain Cell Access transformative project. This will support iterative improvement of molecular payloads capable of monitoring and manipulating neural cell activity and that can be delivered to specific brain cell types using targeting technologies.
Researchers will map brain circuits controlling behaviors, thoughts, and moods.
Scientists know both a lot and very little about the brain. With billions of neurons and trillions of connections among them, and the experimental limitations of examining the seat of consciousness and bodily function, studying the human brain is a technical, theoretical, and ethical challenge.
Using organoids to model early development, researchers used an emerging microscopy technology to see that new neurons struggled to reach their developmental destination
Each year, the initiative celebrates some standout and especially creative examples of such advances in the “Show Us Your BRAINs! Photo & Video Contest. During most of August, I’ll share some of the most eye-catching developments in our blog series, The Amazing Brain.
This Funding Opportunity Announcement (FOA) from the NIH Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative is intended to support the establishment of facilities at minority-serving institutions (MSIs) and Institutional Development Award (IDeA)-eligible institutions for scaled production and distribution of brain cell type-specific access and manipulation reagents.